LONDON - Allergy Therapeutics Ltd. met the target of £15 million (US$26.7 million) in its listing on the Alternative Investment Market in London, but fell short of the hoped-for valuation of £55 million, placing 23 million shares at 73 pence each for a market capitalization of £46 million. (BioWorld International)